Distinct inflammatory markers in primary and secondary dengue infection: can cytokines CXCL5, CXCL9, and CCL17 act as surrogate markers?

References

• Kumar K, Singh PK, Tomar J, et al. Dengue: epidemiology, prevention and pressing need for vaccine development. Asian Pac J Trop Med. 2010;3(12):997–1000.
   Web of Science ®Google Scholar
• Wang SH, Syu WJ, Hu ST. Identification of the homotypic interaction domain of the core protein of dengue virus type 2. J Gen Virol. 2004;85(8):2307–2314.
   PubMedGoogle Scholar
• Yue Y, Sun J, Liu X, et al. Spatial analysis of dengue fever and exploration of its environmental and socio-economic risk factors using ordinary least squares: a case study in five districts of Guangzhou City, China, 2014. Int J Infect Dis. 2018;75:39–48.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang J, Cheng X, et al. The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: a systematic review and meta-analysis. PLOS Negl Trop Dis. 2021;15(4):e0009337.
   PubMed Web of Science ®Google Scholar
• Ganeshkumar P, Murhekar MV, Poornima V, et al. Dengue infection in India: a systematic review and meta-analysis. PLOS Negl Trop Dis. 2018;12(7):e0006618.
   PubMed Web of Science ®Google Scholar
• Jing Q, Wang M. Dengue epidemiology. Glob Health J. 2019;3(2):37–45.
   Google Scholar
• Raheel U, Faheem M, Riaz MN, et al. Dengue fever in the Indian subcontinent: an overview. J Infect Dev Ctries. 2011;5(4):239–247.
   PubMed Web of Science ®Google Scholar
• Patro ARK, Mohanty S, Prusty BK, et al. Cytokine signature associated with disease severity in dengue. Viruses. 2019;11(1):34.
   PubMed Web of Science ®Google Scholar
• Normile D. Tropical medicine. Surprising new dengue virus throws a spanner in disease control efforts. Science. 2013;342(6157):415.
   PubMed Web of Science ®Google Scholar
• Ripoll DR, Wallqvist A, Chaudhury S. Molecular simulations reveal the role of antibody fine specificity and viral maturation state on antibody-dependent enhancement of infection in dengue virus. Front Cell Infect Microbiol. 2019;9:200.
   PubMed Web of Science ®Google Scholar
• Hadinegoro SRS. The revised WHO dengue case classification: does the system need to be modified? Paediatr Int Child Health. 2012;32(s1)(suppl 1):33–38.
   Google Scholar
• Saeed MA, Attia TH. Dengue and dengue hemorrhagic fever. Afro-Egypt J Infect Endem Dis. 2015;5(3):189–200.
   Google Scholar
• Kumarasamy V, Wahab AH, Chua SK, et al. Evaluation of a commercial dengue NS1 antigen-capture ELISA for laboratory diagnosis of acute dengue virus infection. J Virol Methods. 2007;140(1–2):75–79.
   PubMed Web of Science ®Google Scholar
• Bäck AT, Lundkvist A. Dengue viruses – an overview. Infect Ecol Epidemiol. 2013;3(1):19839.
   Google Scholar
• Butthep P, Chunhakan S, Yoksan S, et al. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr Infect Dis J. 2012;31(12):e232–e238.
   PubMed Web of Science ®Google Scholar
• Rathore APS, St John AL. Immune responses to dengue virus in the skin. Open Biol. 2018;8(8):180087.
   PubMed Web of Science ®Google Scholar
• Amin P, Acicbe Ö, Hidalgo J, et al. Dengue fever: report from the task force on tropical diseases by the world federation of societies of intensive and critical care medicine. J Crit Care. 2018;43:346–351.
   PubMed Web of Science ®Google Scholar
• Huang J, Liang W, Chen S, et al. Serum cytokine profiles in patients with dengue fever at the acute infection phase. Dis Markers. 2018;2018:8403937.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Kunkel SL, Burdick MD, et al. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol Invest. 1992;21(6):589–596.
   PubMed Web of Science ®Google Scholar
• Williams A. CXC chemokine family. In: Encyclopedia of Respiratory Medicine. 2nd ed. Elsevier; 2022. p. 357–379. doi: 10.1016/B978-0-08-102723-3.00252-3
   Google Scholar
• Tokunaga R, Zhang WU, Naseem M, et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40–47.
   PubMed Web of Science ®Google Scholar
• Fulkerson PC, Rothenberg ME. Chemokines, CXC, CXCL9 (MIG). Encyclopedia of Respiratory Medicine. Academic Press; 2006. p. 398–402. doi: 10.1016/B0-12-370879-6/00471-3
   Google Scholar
• Lacy P. Eosinophil cytokines in allergy. In: Cytokine effector functions in tissues. Academic Press; 2017. p. 173–218. doi: 10.1016/B978-0-12-804214-4.00011-7
   Google Scholar
• Mustafa Z, Khan HM, Azam M, et al. Insight into the seroepidemiology and dynamics of circulating serotypes of dengue virus over a 4 year period in western Uttar Pradesh, India. Access Microbiol. 2023;5(6):acmi000567. doi: 10.1099/acmi.0.000567.v4
   Google Scholar
• World Health Organization. Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever; 2011.
   Google Scholar
• Shu PY, Chen LK, Chang SF, et al. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol. 2003;10(4):622–630. doi: 10.1128/cdli.10.4.622-630.2003
   PubMedGoogle Scholar
• Soe HJ, Manikam R, Raju CS, et al. Correlation of host inflammatory cytokines and immune-related metabolites, but not viral NS1 protein, with disease severity of dengue virus infection. PLOS ONE. 2020;15(8):e0237141. doi: 10.1371/journal.pone.0237141
   PubMed Web of Science ®Google Scholar
• Chang MS, McNinch J, Basu R, et al. Cloning and characterization of the human neutrophil-activating peptide (ENA-78) gene. J Biol Chem. 1994;269(41):25277–25282. doi: 10.1016/S0021-9258(18)47243-2
   PubMed Web of Science ®Google Scholar
• Liu Y, Mei J, Gonzales L, et al. IL-17A and TNF-α exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J Immunol. 2011;186(5):3197–3205. doi: 10.4049/jimmunol.1002016
   PubMed Web of Science ®Google Scholar
• Shen F, Ruddy MJ, Plamondon P, et al. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin‐17‐and TNF-α‐induced genes in bone cells. J Leukoc Biol. 2005;77(3):388–399. doi: 10.1189/jlb.0904490
   PubMed Web of Science ®Google Scholar
• Chakravarti A, Kumaria R. Circulating levels of tumour necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J Med Res. 2006;123(1):25–30.
   PubMed Web of Science ®Google Scholar
• Meena AA, Murugesan A, Sopnajothi S, et al. Increase of plasma TNF-α is associated with decreased levels of blood platelets in clinical dengue infection. Viral Immunol. 2020;33(1):54–60. doi: 10.1089/vim.2019.0100
   PubMed Web of Science ®Google Scholar
• Schnyder‐Candrian S, Strieter RM, Kunkel SL, et al. Interferon‐α and interferon‐γ down‐regulate the production of interleukin‐8 and ENA‐78 in human monocytes. J Leukoc Biol. 1995;57(6):929–935. doi: 10.1002/jlb.57.6.929
   PubMed Web of Science ®Google Scholar
• Priyadarshini D, Gadia RR, Tripathy A, et al. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLOS ONE. 2010;5(1):e8709. doi: 10.1371/journal.pone.0008709
   PubMed Web of Science ®Google Scholar
• Cruz Hernández SI, Puerta-Guardo HN, Flores Aguilar H, et al. Primary dengue virus infections induce differential cytokine production in Mexican patients. Mem Inst Oswaldo Cruz. 2016;111(3):161–167. doi: 10.1590/0074-02760150359
   PubMed Web of Science ®Google Scholar
• Gowri Sankar S, Mowna Sundari T, Alwin Prem Anand A. Emergence of dengue 4 as dominant serotype during 2017 outbreak in South India and associated cytokine expression profile. Front Cell Infect Microbiol. 2021;11:681937. doi: 10.3389/fcimb.2021.681937
   PubMed Web of Science ®Google Scholar
• Patra G, Mallik S, Saha B, et al. Assessment of chemokine and cytokine signatures in patients with dengue infection: a hospital-based study in Kolkata, India. Acta Trop. 2019;190:73–79. doi: 10.1016/j.actatropica.2018.10.017
   PubMed Web of Science ®Google Scholar
• Fares-Gusmao R, Rocha BC, Sippert E, et al. Differential pattern of soluble immune markers in asymptomatic dengue, west Nile and Zika virus infections. Sci Rep. 2019;9(1):17172. doi: 10.1038/s41598-019-53645-w
   PubMedGoogle Scholar
• Teo TH, Howland SW, Claser C, et al. Co‐infection with Chikungunya virus alters trafficking of pathogenic CD8+ T cells into the brain and prevents Plasmodium-induced neuropathology. EMBO Mol Med. 2018;10(1):121–138. doi: 10.15252/emmm.201707885
   PubMed Web of Science ®Google Scholar
• Dalrymple NA, Mackow ER. Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol. 2012;86(12):6408–6415. doi: 10.1128/JVI.00213-12
   PubMed Web of Science ®Google Scholar
• De Zutter A, Crijns H, Berghmans N, et al. The chemokine-based peptide, CXCL9(74-103), inhibits angiogenesis by blocking heparan sulfate proteoglycan-mediated signaling of multiple endothelial growth factors. Cancers (Basel). 2021;13(20):5090. doi: 10.3390/cancers13205090
   PubMed Web of Science ®Google Scholar
• Whiting D, Hsieh G, Yun JJ, et al. Chemokine monokine induced by IFN-γ/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J Immunol. 2004;172(12):7417–7424. doi: 10.4049/jimmunol.172.12.7417
   PubMed Web of Science ®Google Scholar
• Guabiraba R, Marques RE, Besnard AG, et al. Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice. PLOS ONE. 2010;5(12):e15680. doi: 10.1371/journal.pone.0015680
   PubMed Web of Science ®Google Scholar
• Sumiyoshi K, Nakao A, Setoguchi Y, et al. TGF-β/Smad signaling inhibits IFN-γ and TNF-α-induced TARC (CCL17) production in HaCaT cells. J Dermatol Sci. 2003;31(1):53–58. doi: 10.1016/s0923-1811(02)00141-x
   PubMed Web of Science ®Google Scholar
• Shibata S, Maeda S, Kondo N, et al. Identification of the signaling pathway of TNF-α-induced CCL17/TARC transcription in a canine keratinocyte cell line. Vet Immunol Immunopathol. 2011;139(2–4):90–98. doi: 10.1016/j.vetimm.2010.08.008
   PubMed Web of Science ®Google Scholar
• Ahrens B, Schulz G, Bellach J, et al. Chemokine levels in serum of children with atopic dermatitis with regard to severity and sensitization status. Pediatr Allergy Immunol. 2015;26(7):634–640. doi: 10.1111/pai.12431
   PubMedGoogle Scholar
• Feng Y, Yin H, Mai G, et al. Elevated serum levels of CCL17 correlate with increased peripheral blood platelet count in patients with active tuberculosis in China. Clin Vaccine Immunol. 2011;18(4):629–632. doi: 10.1128/CVI.00493-10
   PubMedGoogle Scholar
• Wang L, Fan Y, Dou X. Specific chemokines CCL2 and CCL17 are correlated with hepatic necro-inflammation in chronic hepatitis B patients with normal/mildly elevated alanine aminotransaminase levels. Int J Clin Exp Med. 2018;11(9):9371–9379.
   Web of Science ®Google Scholar
• Riezu-Boj JI, Larrea E, Aldabe R, et al. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. J Hepatol. 2011;54(3):422–431. doi: 10.1016/j.jhep.2010.07.014
   PubMed Web of Science ®Google Scholar
• Lee KM, Prasad V, Achuthan A, et al. Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice. Osteoarthritis Cartilage. 2020;28(4):486–491. doi: 10.1016/j.joca.2020.01.012
   PubMed Web of Science ®Google Scholar
• OhAinle M, Balmaseda A, Macalalad AR, et al. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med. 2011;3(114):114ra128–114ra128. doi: 10.1126/scitranslmed.3003084
   PubMed Web of Science ®Google Scholar
• Rico-Hesse R, Harrison LM, Salas RA, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology. 1997;230(2):244–251. doi: 10.1006/viro.1997.8504
   PubMed Web of Science ®Google Scholar